Literature DB >> 8225616

Circulating tumor necrosis factor alpha (TNF), soluble TNF receptors, and interleukin-6 in human subacute bacterial endocarditis.

W V Kern1, A Engel, S Schieffer, O Prümmer, P Kern.   

Abstract

Cell surface components of viridans streptococci and enterococci have been shown to stimulate the release of tumor necrosis factor alpha (TNF) and interleukin-6 from monocytes/macrophages. In the sera from 10 patients with subacute enterococcal or streptococcal endocarditis, however, the levels of both cytokines were low or undetectable, with elevated TNF levels on admission in 3 patients with complicated disease. Soluble TNF receptor levels were significantly elevated compared with those of healthy controls. When patients with malaria were used as a control group of acute intravascular infection with high circulating TNF values, the ratio between soluble TNF receptors and TNF on admission was significantly greater in the patients with subacute bacterial endocarditis. Besides different amounts of circulating TNF, enhanced TNF receptor shedding may have an important role in the pathogenesis of subacute versus acute clinical disease following human intravascular infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8225616      PMCID: PMC281334          DOI: 10.1128/iai.61.12.5413-5416.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

Review 1.  Tumor necrosis, cachexia, shock, and inflammation: a common mediator.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

2.  Effects of interleukin-1, lipopolysaccharide, and streptococci on procoagulant activity of cultured human cardiac valve endothelial and stromal cells.

Authors:  T A Drake; M Pang
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

Review 3.  Physiology of lipoteichoic acids in bacteria.

Authors:  W Fischer
Journal:  Adv Microb Physiol       Date:  1988       Impact factor: 3.517

4.  Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor.

Authors:  M Lantz; U Gullberg; E Nilsson; I Olsson
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

5.  An inhibitor of the toxicity of tumour necrosis factor in the serum of patients with sarcoidosis, tuberculosis and Crohn's disease.

Authors:  N Foley; C Lambert; M McNicol; N Johnson; G A Rook
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

6.  Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.

Authors:  M Brockhaus; H J Schoenfeld; E J Schlaeger; W Hunziker; W Lesslauer; H Loetscher
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

7.  Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases.

Authors:  W Kern; E Kurrle; T Schmeiser
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

Review 8.  Infective endocarditis at a large community teaching hospital, 1980-1990. A review of 210 episodes.

Authors:  C Watanakunakorn; T Burkert
Journal:  Medicine (Baltimore)       Date:  1993-03       Impact factor: 1.889

9.  The clinical manifestations of infective endocarditis.

Authors:  P E Hermans
Journal:  Mayo Clin Proc       Date:  1982-01       Impact factor: 7.616

10.  Shedding of tumor necrosis factor receptors by activated human neutrophils.

Authors:  F Porteu; C Nathan
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

View more
  8 in total

1.  Interleukin-10 regulates the tissue factor activity of monocytes in an in vitro model of bacterial endocarditis.

Authors:  M H Veltrop; J A Langermans; J Thompson; M J Bancsi
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Role of monocytes in experimental Staphylococcus aureus endocarditis.

Authors:  M H Veltrop; M J Bancsi; R M Bertina; J Thompson
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

3.  Release of soluble tumor necrosis factor receptors in Mediterranean spotted fever rickettsiosis.

Authors:  W V Kern; J Oristrell; F Segura-Porta; P Kern
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

4.  Serial measurement of the circulating levels of tumour necrosis factor and its soluble receptors 1 and 2 for monitoring leprosy patients during multidrug treatment.

Authors:  Rosane Dias Costa; Vanessa Amaral Mendonça; Frederico Marianetti Soriani; Sandra Lyon; Rachel Adriana Penido; Ana Maria Duarte Dias Costa; Marina Dias Costa; Fabio de Souza Terra; Mauro Martins Teixeira; Carlos Mauricio de Figueiredo Antunes; Antonio Lúcio Teixeira
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-12       Impact factor: 2.743

5.  Persistent p55TNFR expression impairs T cell responses during chronic tuberculosis and promotes reactivation.

Authors:  Ivy M Dambuza; Roanne Keeton; Nai-Jen Hsu; Nasiema Allie; Valérie F J Quesniaux; Bernhard Ryffel; Muazzam Jacobs
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

6.  Biomarker-based diagnosis of pacemaker and implantable cardioverter defibrillator pocket infections: A prospective, multicentre, case-control evaluation.

Authors:  Carsten Lennerz; Hrvoje Vrazic; Bernhard Haller; Siegmund Braun; Tobias Petzold; Ilka Ott; Agnes Lennerz; Jonathan Michel; Patrick Blažek; Isabel Deisenhofer; Peter Whittaker; Christof Kolb
Journal:  PLoS One       Date:  2017-03-06       Impact factor: 3.240

7.  Changes in inflammatory and vasoactive mediator profiles during valvular surgery with or without infective endocarditis: A case control pilot study.

Authors:  Mahmoud Diab; Raphael Tasar; Christoph Sponholz; Thomas Lehmann; Mathias W Pletz; Michael Bauer; Frank M Brunkhorst; Torsten Doenst
Journal:  PLoS One       Date:  2020-02-03       Impact factor: 3.240

8.  Cytokine Signature in Infective Endocarditis.

Authors:  Izabella Rodrigues Araújo; Teresa Cristina Abreu Ferrari; Andréa Teixeira-Carvalho; Ana Carolina Campi-Azevedo; Luan Vieira Rodrigues; Milton Henriques Guimarães Júnior; Thais Lins Souza Barros; Cláudio Léo Gelape; Giovane Rodrigo Sousa; Maria Carmo Pereira Nunes
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.